Alcohol use during COVID-19 in adults with severe untreated AUD.
Alcohol Consumption
Alcohol Use Disorder
COVID-19
Community Sample
Untreated AUD
Journal
Alcoholism treatment quarterly
ISSN: 0734-7324
Titre abrégé: Alcohol Treat Q
Pays: United States
ID NLM: 8411865
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
8
8
2022
pubmed:
9
8
2022
medline:
9
8
2022
Statut:
ppublish
Résumé
Evidence demonstrating increased alcohol use during COVID-19 comes from low- to moderate-alcohol use samples and has yet to use adults with severe but untreated AUD. Using a community sample of adults with severe AUD, this exploratory, cross-sectional study examined associations of COVID-19 alcohol use. Participants were recruited for a phase-II RCT. Only baseline measures, completed prior to randomization, were analyzed in the present study. Key variables were alcohol consumption, COVID-19-related worries and experiences, and qualitative responses of 1) alcohol use and 2) positive changes during COVID-19. 176 pariticpants recruited since COVID-19 were on average 41.4 years old, 49.1% female, and 79% White. Participants drank alcohol nearly 23 of the past 30 days, consumed 7 standard drinks per drinking day, and nearly 90% reported increased alcohol use. More heavy episodic drinking was reported in the first six-months of COVID-19 and more COVID-related concerns in the most recent six-months. Participants reported drinking increased due to "more time on their hands", but the pandemic also "strengthened relationships". Results affirm an increase in alcohol use during COVID-19 in adults with severe, untreated AUD. Findings underscore the need to understand how alcohol use and pandemic-related circumstances may influence one another for adults with severe AUD.
Identifiants
pubmed: 35937159
doi: 10.1080/07347324.2022.2060156
pmc: PMC9355046
mid: NIHMS1793627
doi:
Types de publication
Journal Article
Langues
eng
Pagination
299-310Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA026815
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest Statement The authors report there are no competing interests to declare.
Références
PLoS One. 2021 Apr 1;16(4):e0249678
pubmed: 33793672
BMJ. 2020 May 20;369:m1987
pubmed: 32434792
Drug Alcohol Depend. 2007 Jan 12;86(2-3):214-21
pubmed: 16919401
Alcohol Alcohol. 2020 Jun 25;55(4):350-353
pubmed: 32400859
BMJ Open. 2020 Jul 12;10(7):e039226
pubmed: 32660955
BMJ Open. 2020 Nov 26;10(11):e044276
pubmed: 33243820
J Addict Med. 2020 Dec;14(6):e293-e296
pubmed: 33156267
Drug Alcohol Rev. 2020 May;39(4):301-304
pubmed: 32358884
J Addict Med. 2021 Jul-Aug 01;15(4):341-344
pubmed: 33105169
Soc Work Public Health. 2016 Oct;31(6):481-9
pubmed: 27210830
Addiction. 2015 Jun;110(6):986-93
pubmed: 25619110
J Stud Alcohol Drugs. 2012 Jul;73(4):647-56
pubmed: 22630803
Drug Alcohol Depend. 2011 Jan 15;113(2-3):215-21
pubmed: 20828944
Minerva Gastroenterol Dietol. 2020 Jun;66(2):90-92
pubmed: 32221278
Prev Med. 2021 Dec;153:106854
pubmed: 34695505
Am J Drug Alcohol Abuse. 2021 Nov 2;47(6):730-736
pubmed: 34043919
Patient Prefer Adherence. 2010 Mar 24;4:45-9
pubmed: 20390058
J Subst Abuse Treat. 2012 Sep;43(2):161-7
pubmed: 22138200
Alcohol Clin Exp Res. 2005 Oct;29(10):1858-68
pubmed: 16269916
JAMA Netw Open. 2020 Sep 1;3(9):e2022942
pubmed: 32990735
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057
pubmed: 32790653
J Anxiety Disord. 2021 Jun;81:102418
pubmed: 34004367
J Stud Alcohol Drugs. 2021 Nov;82(6):776-781
pubmed: 34762037
Exp Clin Psychopharmacol. 2021 Dec;29(6):739-749
pubmed: 33166163